Ingo Minrath

Ingo Minrath

Auto-generated profile, based on publicly available information

Ingo Minrath

Institute for Biomedical Engineering, University of Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
SPSvea Petersen
Svea Petersen
SKSebastian Kaule
Sebastian Kaule
MTMichael Teske
Michael Teske
IMIngo Minrath
Ingo Minrath
KSKlaus-Peter Schmitz
Klaus-Peter Schmitz
KSKatrin Sternberg
Katrin Sternberg
The development of drug‐eluting coatings based on hyaluronic acid (HA) is especially promising for implant‐associated local drug delivery (LDD) systems, whose implantation provokes high insertion forces, as, for instance, cochlear implants or drug‐coated balloons (DCB). The lubricious character of HA can then reduce the coefficient of friction and serve as drug reservoir simultaneously. In this context, we investigated several plasma‐ and wet‐chemical methods for the deposition of HA‐based coatings with LDD function on polyamide 12 as a model implant surface, conventionally used for DCB. In contrast to aminosilane, epoxy silane surface layers allowed the covalent attachment of a smooth and uniform HA base layer, which provided good adherence of further HA layers deposited by manual dip coating at a subsequent processing stage. The applied HA‐crosslinking procedure during dip coating influences the transfer and release of paclitaxel, which could be reproducibly incorporated via infiltration. While crosslinking with N‐(3‐dimethylaminopropyl)‐N′‐ethylcarbodiimide hydrochloride provided HA coatings on DCB, which allowed for an efficient paclitaxel transfer upon expansion in a vessel model, crosslinking with glutardialdehyde resulted in a slower drug release being more appropriate for implants with longer residence time in the body. The developed HA coating is hence well suited for spontaneous and sustained LDD.